TY  - RPRT
TI  - Capitalizing on paradoxical activation of the MAPK pathway for treatment of Imatinib-resistant mast cell leukemia and chronic myelogenous leukemia
AU  - Wilhelm, T.
AU  - Simons, I.
AU  - Stuth, C.
AU  - Mohta, V.
AU  - Mülfarth, R.
AU  - Nitsche, M.
AU  - Maschke-Neuss, K.
AU  - Arock, M.
AU  - Huber, M.
PY  - 2020
DO  - 10.1101/2020.08.31.266734
UR  - https://www.biorxiv.org/content/10.1101/2020.08.31.266734v1
ID  - 10.1101/2020.08.31.266734
ER  -